Isbn: 9780826184412 - handbook of hematologic malignancies (5 resultados)

ISBN: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (5)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: Demos Medical, 2025

    0826184413 / 9780826184412

    • Tapa blanda

    Librería: Books From California, Simi Valley, CA, Estados Unidos de AmericaBooks From California

    Vendedor de 4 estrellas
    Contactar con el vendedor

    Condición: Usado - Bueno

    EUR 50,52

    Envío por EUR 4,39 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponibles

    paperback. Condición: Very Good. The copy shows minor external wear, but is in otherwise clean condition.

  • Idioma: Inglés

    Editorial: Springer Publishing Co Inc, New York, 2025

    0826184413 / 9780826184412

    • Tapa blanda

    Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 109,57

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: 1 disponibles

    Paperback. Condición: new. Paperback. Handbook of Hematologic Malignancies 3rd Edition remains an indispensable resource for busy hematologists, hematologic oncologists, hematopathologists, oncology advanced practice providers, oncology nurses, and trainees. This significantly revised and completely updated edition is meticulously organized to provide concise, essential information on diagnosis, prognosis, therapeutic management, and clinical trial opportunities for each hematologic malignancy. Each chapter features detailed figures that illustrate the hematopathologic characteristics of diseases, along with tables designed to simplify the review of differential diagnoses, prognostic scoring systems, molecular profiles, and therapeutic options.With over 35 new FDA-approved indications since the second editionfeaturing groundbreaking advancements such as CAR-T therapythis handbook serves as a quick reference for practice-changing information on complex diagnostic dilemmas, frontline treatments, refractory scenarios, and relapse management. Purchase includes online access via most mobile devices or computers.Key Features:New chapters on precursor states in myeloid malignancies (CHIP/CCUS), familial/inherited risks of hematologic malignancies, CAR-T versus Bispecific Treatment, and mechanisms of CAR-T resistance.Entirely new board-style questions, enhancing critical thinking and knowledge application with every clinical chapter.Features updated chapters that concisely outline new standards of care and management considerations, accompanied by key references for further reading.Highlights essential diagnostic tools, including updated 2022 WHO and ICC classification systems, that aid in conducting critical differential diagnoses and resolving complex diagnostic dilemmas.Delivers key updates on potential practice-changing clinical trials and paradigm-shifting treatment considerations within each disease-based chapter, ensuring clinicians stay at the forefront of hematologic oncology. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Idioma: Inglés

    Editorial: Demos Medical, 2025

    0826184413 / 9780826184412

    • Tapa blanda

    Librería: California Books, Miami, FL, Estados Unidos de AmericaCalifornia Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 109,58

     Gastos de envío gratis 
    Se envía dentro de Estados Unidos de America

    Cantidad disponible: Más de 20 disponibles

    Condición: New.

  • Idioma: Inglés

    Editorial: Demos Medical Pub, 2025

    0826184413 / 9780826184412

    • Tapa blanda

    Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 137,62

    Envío por EUR 14,52 
    Se envía de Reino Unido a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Paperback. Condición: Brand New. 3rd new edition. 660 pages. 8.00x5.00x8.00 inches. In Stock.

  • Idioma: Inglés

    Editorial: Springer Publishing Company Jun 2025, 2025

    0826184413 / 9780826184412

    • Tapa blanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 142,69

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. Neuware - Handbook of Hematologic Malignancies 3rd Edition remains an indispensable resource for busy hematologists, hematologic oncologists, hematopathologists, oncology advanced practice providers, oncology nurses, and trainees. This significantly revised and completely updated edition is meticulously organized to provide concise, essential information on diagnosis, prognosis, therapeutic management, and clinical trial opportunities for each hematologic malignancy. Each chapter features detailed figures that illustrate the hematopathologic characteristics of diseases, along with tables designed to simplify the review of differential diagnoses, prognostic scoring systems, molecular profiles, and therapeutic options.With over 35 new FDA-approved indications since the second edition-featuring groundbreaking advancements such as CAR-T therapy-this handbook serves as a quick reference for practice-changing information on complex diagnostic dilemmas, frontline treatments, refractory scenarios, and relapse management. Purchase includes online access via most mobile devices or computers.Key Features:- New chapters on precursor states in myeloid malignancies (CHIP/CCUS), familial/inherited risks of hematologic malignancies, CAR-T versus Bispecific Treatment, and mechanisms of CAR-T resistance.- Entirely new board-style questions, enhancing critical thinking and knowledge application with every clinical chapter.- Features updated chapters that concisely outline new standards of care and management considerations, accompanied by key references for further reading.- Highlights essential diagnostic tools, including updated 2022 WHO and ICC classification systems, that aid in conducting critical differential diagnoses and resolving complex diagnostic dilemmas.- Delivers key updates on potential practice-changing clinical trials and paradigm-shifting treatment considerations within each disease-based chapter, ensuring clinicians stay at the forefront of hematologic oncology.…